Search clinical trials for: Vinorelbine, cisplatin

Total 3724 results

Allarity Therapeutics

Completed

Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours (LiPlaCis)

Phase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer

Denmark
QLT Inc.

Terminated

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Stage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.

Carcinoma, Non-Small-Cell Lung
University Health Network, Toronto

Completed

Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

Canada
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company; United States Department of Defense

Completed

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Lung Cancer

United States
Betta Pharmaceuticals Co., Ltd.

Unknown

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

Non-small-cell Lung Cancer

China
Istituto Nazionale per lo Studio e la Cura dei...
NCIC Clinical Trials Group

Unknown

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lung Cancer

Italy
The Netherlands Cancer Institute
Karolinska Institutet; UMC Utrecht; Maastricht Radiation Oncology; The Christie... and other collaborators

Active, not recruiting

Adaptive Radiation Treatment for Head and Neck Cancer (ARTFORCE)

Head and Neck Cancer

Spain, Netherlands, Sweden, France, United Kingdom
Ludwig-Maximilians - University of Munich

Completed

Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer

Metastatic Breast Cancer
Radboud University Medical Center

Completed

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Melanoma

Netherlands
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Terminated

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Lung Cancer

United States, Australia
AIO-Studien-gGmbH
Novartis Pharmaceuticals; iOMEDICO AG

Completed

Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer (VicTORia)

Her2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast Cancer

Germany
Georgetown University

Terminated

Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer

Head and Neck Squamous Cell Cancer

United States
Zhiyong Yu

Unknown

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

Breast Cancer | Chemotherapy Effect | Disease-free Survival
Curis, Inc.

Completed

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

Head and Neck Cancer

United States
Southern Europe New Drug Organization
Pierre Fabre Laboratories; Agennix

Unknown

Satraplatin and Vinorelbine in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
AstraZeneca

Completed

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Non-Small Cell Lung Cancer

France
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
ARCAGY/ GINECO GROUP

Completed

CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto

Cervix Cancer

France
University of Aarhus
Pierre Fabre Laboratories

Completed

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer (XeNa)

Breast Cancer

Denmark
Eli Lilly and Company

Completed

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Carcinoma | Lung Neoplasms | Non-Small-Cell Lung Carcinoma | Cancer of the Lung

United States, Canada, Puerto Rico
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

Breast Cancer

China
National Cancer Institute, Naples

Completed

G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients (G-Step)

Small Cell Lung Cancer

Italy
Shi Yanxia

Recruiting

PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer (PERS)

Breast Cancer | Effects of Chemotherapy | Breast Cancer Model

China
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH); Radiation...

Completed

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Terminated

A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
New Mexico Cancer Care Alliance

Completed

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

Cancer

United States
Pierre Fabre Pharma GmbH
Winicker Norimed GmbH

Completed

Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria (StepUp)

Breast Cancer | Non-Small-Cell Lung Cancer

Germany, Austria
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lung Cancer

United States
GlaxoSmithKline

Completed

Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States, Canada, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Metronome Therapeutics

Unknown

Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies

Nonhematologic Malignancies

United States
Liaoning Tumor Hospital & Institute

Not yet recruiting

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Triple-negative Breast Cancer
National Cancer Institute (NCI)

Completed

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors

Neoplasms

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Breast Cancer

United States
Taiwan Liposome Company

Completed

Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy

Cancer

United States, Taiwan
Guangdong Association of Clinical Trials

Terminated

Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer

Lung Neoplasm Malignant

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer (Pyrotinib)

Breast Cancer | Brain Metastases

China
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Neoplasms, Connective and Soft Tissue | Osteosarcomas | Medulloblastomas | Rhabdomyosarcomas | Ewing Tumor | Neuroblastomas

France
Tianjin Medical University Cancer Institute and...
Roche Pharma AG

Unknown

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

Non-small Cell Lung Cancer Stage III

China
Swiss Group for Clinical Cancer Research

Completed

Vinorelbine in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

Switzerland
Hematology Oncology Consultants
Ortho Biotech, Inc.

Unknown

A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Masonic Cancer Center, University of Minnesota

Withdrawn

Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer

Cervical Cancer

United States
American University of Beirut Medical Center
Sanofi

Terminated

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma

Breast Neoplasms

Lebanon
Spectrum Pharmaceuticals, Inc

Withdrawn

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States, Canada, Belgium, Israel
American College of Radiology Imaging Network
National Cancer Institute (NCI); Radiation Therapy Oncology Group

Unknown

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States, Canada, Korea, Republic of
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)

Non Small Cell Lung Cancer
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lung Cancer

United States
Zhejiang Cancer Hospital
Proswell Medical Corporation

Recruiting

Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC

Metastatic Breast Cancer

China

Search clinical trials for: Vinorelbine, cisplatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations